Catalyst Pharmaceuticals, Inc. (CPRX)
31.28
-0.04
(-0.14%)
USD |
NASDAQ |
May 27, 13:06
Catalyst Pharmaceuticals Free Cash Flow : 208.13M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ADMA Biologics, Inc. | 107.55M |
| Inovio Pharmaceuticals, Inc. | -83.57M |
| United Therapeutics Corp. | 1.011B |
| Regeneron Pharmaceuticals, Inc. | 3.791B |
| Agios Pharmaceuticals, Inc. | -384.73M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 59.59M |
| Cash from Investing (Quarterly) | -0.027M |
| Cash from Financing (Quarterly) | -12.87M |
| Free Cash Flow Per Share (Quarterly) | 0.4693 |
| Free Cash Flow to Equity (Quarterly) | 59.67M |
| Free Cash Flow to Firm (Quarterly) | 59.56M |
| Free Cash Flow Yield | 5.23% |